| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$131,103 |
|
|
|
Indirect Value
|
$114,705 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$245,808 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-21 |
4 |
AS |
$22.22 |
$106,656 |
I/I |
(4,800) |
315,511 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-04-10 |
4 |
AS |
$37.04 |
$144,456 |
I/I |
(3,900) |
316,037 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-29 |
4 |
AS |
$39.81 |
$155,637 |
I/I |
(3,900) |
319,937 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-20 |
4 |
AS |
$21.99 |
$105,552 |
I/I |
(4,800) |
320,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-28 |
4 |
AS |
$36.75 |
$145,909 |
I/I |
(3,900) |
323,837 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-08 |
4 |
AS |
$22.96 |
$110,208 |
I/I |
(4,800) |
325,111 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-23 |
4 |
AS |
$34.05 |
$859,606 |
D/D |
(24,100) |
325,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-15 |
4 |
AS |
$38.73 |
$151,047 |
I/I |
(3,900) |
327,737 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-07 |
4 |
AS |
$22.80 |
$109,440 |
I/I |
(4,800) |
329,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-14 |
4 |
AS |
$39.10 |
$156,906 |
I/I |
(3,900) |
331,637 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
D |
$40.45 |
$47,569 |
D/D |
(1,176) |
332,243 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-09 |
4 |
D |
$38.49 |
$782,271 |
D/D |
(20,324) |
334,618 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-24 |
4 |
AS |
$21.32 |
$102,336 |
I/I |
(4,800) |
334,711 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
AS |
$36.13 |
$140,907 |
I/I |
(3,900) |
335,537 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
AS |
$35.22 |
$140,984 |
I/I |
(3,900) |
339,437 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-23 |
4 |
AS |
$21.19 |
$101,712 |
I/I |
(4,800) |
339,511 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-12 |
4 |
AS |
$39.01 |
$152,139 |
I/I |
(3,900) |
342,138 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-08 |
4 |
AS |
$20.79 |
$99,792 |
I/I |
(4,800) |
344,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-11 |
4 |
AS |
$38.52 |
$150,228 |
I/I |
(3,900) |
346,038 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-16 |
4 |
AS |
$15.57 |
$37,368 |
I/I |
(2,400) |
348,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-07 |
4 |
AS |
$20.25 |
$146,580 |
I/I |
(7,200) |
349,111 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-22 |
4 |
AS |
$30.93 |
$330,735 |
I/I |
(10,000) |
349,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-15 |
4 |
AS |
$15.54 |
$37,296 |
I/I |
(2,400) |
351,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-03 |
4 |
AS |
$13.87 |
$33,288 |
I/I |
(2,400) |
353,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-02 |
4 |
AS |
$13.45 |
$32,280 |
I/I |
(2,400) |
356,178 |
0 |
- |
|
209 Records found
|
|
Page 4 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
